TD Asset Management
PLSE icon

TD Asset Management’s Pulse Biosciences PLSE Stock Holding History

TD Asset Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.84M Buy
+154,066
New +$6.5M 0.01% 706

Other funds holding PLSE

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Griffin Asset Management
Griffin Asset Management New York $934M AUM 18.69% 1-Year Est. Return

TD Asset Management's PLSE Position: Q3 2026 in Review

TD Asset Management opened a new position in Pulse Biosciences (PLSE) in Q3 2026: 154,066 shares worth $7.84M. The stake represents 0.01% of the portfolio and ranks #706 among its holdings.

95 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.

  • TD Asset Management held 154,066 shares of Pulse Biosciences worth $7.84M as of Q3 2026.
  • Pulse Biosciences was a new TD Asset Management position in Q3 2026.
  • Pulse Biosciences made up 0.01% of TD Asset Management's portfolio in Q3 2026, its #706 holding.
  • 95 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.

Based on TD Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.